Jlb & Associates Lowered Its Core Laboratories N V (CLB) Stake, Rothschild Asset Management Decreased Neustar (NSR) Holding

July 11, 2017 - By Vivian Currie

Jlb & Associates Inc decreased Core Laboratories N V (CLB) stake by 44.68% reported in 2016Q4 SEC filing. Jlb & Associates Inc sold 2,945 shares as Core Laboratories N V (CLB)’s stock declined 4.78%. The Jlb & Associates Inc holds 3,646 shares with $437,000 value, down from 6,591 last quarter. Core Laboratories N V now has $4.80 billion valuation. The stock increased 1.03% or $1.06 during the last trading session, reaching $103.74. About shares traded. Core Laboratories N.V. (NYSE:CLB) has declined 5.82% since July 11, 2016 and is downtrending. It has underperformed by 22.52% the S&P500.

Rothschild Asset Management Inc decreased Neustar Inc (NSR) stake by 27.72% reported in 2016Q4 SEC filing. Rothschild Asset Management Inc sold 274,114 shares as Neustar Inc (NSR)’s stock declined 1.64%. The Rothschild Asset Management Inc holds 714,738 shares with $23.87M value, down from 988,852 last quarter. Neustar Inc now has $1.86 billion valuation. It closed at $33.35 lastly. It is down 46.60% since July 11, 2016 and is uptrending. It has outperformed by 29.90% the S&P500.

Rothschild Asset Management Inc increased Lhc Group Inc (NASDAQ:LHCG) stake by 57,782 shares to 506,006 valued at $23.12 million in 2016Q4. It also upped Wolverine World Wide Inc (NYSE:WWW) stake by 108,039 shares and now owns 597,795 shares. Aerojet Rocketdyne Hldgs Inc was raised too.

Among 4 analysts covering Neustar (NYSE:NSR), 0 have Buy rating, 0 Sell and 4 Hold. Therefore 0 are positive. Neustar had 6 analyst reports since August 4, 2015 according to SRatingsIntel. William Blair downgraded the shares of NSR in report on Thursday, December 15 to “Market Perform” rating. On Thursday, December 10 the stock rating was maintained by Deutsche Bank with “Hold”. The stock has “Hold” rating by TheStreet on Friday, September 4. On Tuesday, August 4 the stock rating was upgraded by Zacks to “Hold”.

Since March 6, 2017, it had 0 insider purchases, and 2 sales for $706,945 activity. 12,085 shares were sold by Skorny Henry, worth $403,881.

Investors sentiment decreased to 0.77 in 2016 Q4. Its down 0.13, from 0.9 in 2016Q3. It worsened, as 41 investors sold NSR shares while 80 reduced holdings. 39 funds opened positions while 54 raised stakes. 52.05 million shares or 9.48% less from 57.50 million shares in 2016Q3 were reported. First Trust Advsr Ltd Partnership reported 79,925 shares or 0.01% of all its holdings. Denali Advsrs Limited Liability has 41 shares for 0% of their portfolio. Blackrock Inc has invested 0% in Neustar Inc (NYSE:NSR). Engineers Gate Manager Lp holds 0.04% of its portfolio in Neustar Inc (NYSE:NSR) for 12,316 shares. Grp accumulated 134,849 shares. Blackrock Fund Advsrs reported 1.60M shares stake. Highbridge Cap Mngmt Lc reported 304,597 shares stake. Gemmer Asset Mngmt Ltd Company owns 152 shares or 0% of their US portfolio. Oregon Employees Retirement Fund holds 18,840 shares or 0.01% of its portfolio. Prtn Llc reported 59,700 shares or 0.13% of all its holdings. Advsrs Asset Mngmt Inc owns 1,300 shares or 0% of their US portfolio. Van Berkom & Inc holds 3.05% or 2.28M shares. Ubs Asset Mngmt Americas has 23,595 shares for 0% of their portfolio. Kbc Gru Nv owns 63,256 shares. Parametric Associate Limited Com reported 244,255 shares or 0.01% of all its holdings.

Since January 30, 2017, it had 2 buys, and 0 sales for $35,617 activity. Straughen Michael bought 106 shares worth $12,577. On Monday, January 30 the insider Carnes Martha Z. bought $23,040.

Analysts await Core Laboratories N.V. (NYSE:CLB) to report earnings on July, 19. They expect $0.51 EPS, up 45.71% or $0.16 from last year’s $0.35 per share. CLB’s profit will be $23.60 million for 50.85 P/E if the $0.51 EPS becomes a reality. After $0.42 actual EPS reported by Core Laboratories N.V. for the previous quarter, Wall Street now forecasts 21.43% EPS growth.

Among 20 analysts covering Core Laboratories (NYSE:CLB), 9 have Buy rating, 0 Sell and 11 Hold. Therefore 45% are positive. Core Laboratories had 33 analyst reports since August 24, 2015 according to SRatingsIntel. On Friday, June 10 the stock rating was initiated by JP Morgan with “Overweight”. The firm earned “Buy” rating on Monday, November 30 by Guggenheim. The rating was initiated by KLR Group with “Buy” on Monday, December 14. Citigroup maintained Core Laboratories N.V. (NYSE:CLB) rating on Wednesday, September 28. Citigroup has “Neutral” rating and $110 target. RBC Capital Markets maintained Core Laboratories N.V. (NYSE:CLB) on Friday, October 23 with “Outperform” rating. The firm has “Neutral” rating given on Tuesday, December 13 by UBS. RBC Capital Markets upgraded the stock to “Outperform” rating in Friday, September 18 report. The firm has “Equal-Weight” rating given on Tuesday, April 5 by Stephens. The firm earned “Outperform” rating on Thursday, January 28 by RBC Capital Markets. ABN Amro maintained the stock with “Hold” rating in Monday, April 24 report.